340 related articles for article (PubMed ID: 36177749)
1. Phosphorylation, compartmentalization, and cardiac function.
Collins KB; Scott JD
IUBMB Life; 2023 Apr; 75(4):353-369. PubMed ID: 36177749
[TBL] [Abstract][Full Text] [Related]
2. Protein Kinase A Opposes the Phosphorylation-dependent Recruitment of Glycogen Synthase Kinase 3β to A-kinase Anchoring Protein 220.
Whiting JL; Nygren PJ; Tunquist BJ; Langeberg LK; Seternes OM; Scott JD
J Biol Chem; 2015 Aug; 290(32):19445-57. PubMed ID: 26088133
[TBL] [Abstract][Full Text] [Related]
3. Specificity and spatial dynamics of protein kinase A signaling organized by A-kinase-anchoring proteins.
Pidoux G; Taskén K
J Mol Endocrinol; 2010 May; 44(5):271-84. PubMed ID: 20150326
[TBL] [Abstract][Full Text] [Related]
4. Organizing signal transduction through A-kinase anchoring proteins (AKAPs).
Logue JS; Scott JD
FEBS J; 2010 Nov; 277(21):4370-5. PubMed ID: 20883492
[TBL] [Abstract][Full Text] [Related]
5. The role of A-Kinase anchoring proteins in cAMP-mediated signal transduction pathways.
Alto NM; Scott JD
Cell Biochem Biophys; 2004; 40(3 Suppl):201-8. PubMed ID: 15289655
[TBL] [Abstract][Full Text] [Related]
6. Plugging PKA into ERK scaffolds.
Smith FD; Langeberg LK; Scott JD
Cell Cycle; 2011 Mar; 10(5):731-2. PubMed ID: 21311231
[TBL] [Abstract][Full Text] [Related]
7. Src homology 2 domain-containing phosphatase 2 (Shp2) is a component of the A-kinase-anchoring protein (AKAP)-Lbc complex and is inhibited by protein kinase A (PKA) under pathological hypertrophic conditions in the heart.
Burmeister BT; Taglieri DM; Wang L; Carnegie GK
J Biol Chem; 2012 Nov; 287(48):40535-46. PubMed ID: 23045525
[TBL] [Abstract][Full Text] [Related]
8. Promotion and inhibition of cardiac hypertrophy by A-kinase anchor proteins.
Blant A; Czubryt MP
Can J Physiol Pharmacol; 2012 Sep; 90(9):1161-70. PubMed ID: 22856508
[TBL] [Abstract][Full Text] [Related]
9. Characterization of an A-kinase anchoring protein-like suggests an alternative way of PKA anchoring in Plasmodium falciparum.
Bandje K; Naissant B; Bigey P; Lohezic M; Vayssières M; Blaud M; Kermasson L; Lopez-Rubio JJ; Langsley G; Lavazec C; Deloron P; Merckx A
Malar J; 2016 Apr; 15():248. PubMed ID: 27129434
[TBL] [Abstract][Full Text] [Related]
10. Kinase-anchoring proteins in ciliary signal transduction.
Gopalan J; Wordeman L; Scott JD
Biochem J; 2021 Apr; 478(8):1617-1629. PubMed ID: 33909027
[TBL] [Abstract][Full Text] [Related]
11. Anchoring and scaffold proteins for kinases and phosphatases.
Lester LB; Scott JD
Recent Prog Horm Res; 1997; 52():409-29; discussion 429-30. PubMed ID: 9238861
[TBL] [Abstract][Full Text] [Related]
12. Compartmentalization role of A-kinase anchoring proteins (AKAPs) in mediating protein kinase A (PKA) signaling and cardiomyocyte hypertrophy.
Rababa'h A; Singh S; Suryavanshi SV; Altarabsheh SE; Deo SV; McConnell BK
Int J Mol Sci; 2014 Dec; 16(1):218-29. PubMed ID: 25547489
[TBL] [Abstract][Full Text] [Related]
13. Biochemical Analysis of AKAP-Anchored PKA Signaling Complexes.
Byrne DP; Omar MH; Kennedy EJ; Eyers PA; Scott JD
Methods Mol Biol; 2022; 2483():297-317. PubMed ID: 35286684
[TBL] [Abstract][Full Text] [Related]
14. UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophy.
Wang L; Burmeister BT; Johnson KR; Baillie GS; Karginov AV; Skidgel RA; O'Bryan JP; Carnegie GK
Cell Signal; 2015 May; 27(5):908-22. PubMed ID: 25683917
[TBL] [Abstract][Full Text] [Related]
15. Drugs That Regulate Local Cell Signaling: AKAP Targeting as a Therapeutic Option.
Bucko PJ; Scott JD
Annu Rev Pharmacol Toxicol; 2021 Jan; 61():361-379. PubMed ID: 32628872
[TBL] [Abstract][Full Text] [Related]
16. The A-Kinase Anchoring Protein (AKAP) Glycogen Synthase Kinase 3β Interaction Protein (GSKIP) Regulates β-Catenin through Its Interactions with Both Protein Kinase A (PKA) and GSK3β.
Dema A; Schröter MF; Perets E; Skroblin P; Moutty MC; Deàk VA; Birchmeier W; Klussmann E
J Biol Chem; 2016 Sep; 291(37):19618-30. PubMed ID: 27484798
[TBL] [Abstract][Full Text] [Related]
17. Cell-permeable peptide-based disruption of endogenous PKA-AKAP complexes: a tool for studying the molecular roles of AKAP-mediated PKA subcellular anchoring.
Faruque OM; Le-Nguyen D; Lajoix AD; Vives E; Petit P; Bataille D; Hani EH
Am J Physiol Cell Physiol; 2009 Feb; 296(2):C306-16. PubMed ID: 19073898
[TBL] [Abstract][Full Text] [Related]
18. Functional roles of a C-terminal signaling complex of CaV1 channels and A-kinase anchoring protein 15 in brain neurons.
Marshall MR; Clark JP; Westenbroek R; Yu FH; Scheuer T; Catterall WA
J Biol Chem; 2011 Apr; 286(14):12627-39. PubMed ID: 21224388
[TBL] [Abstract][Full Text] [Related]
19. Potential therapeutic applications of AKAP disrupting peptides.
Murabito A; Cnudde S; Hirsch E; Ghigo A
Clin Sci (Lond); 2020 Dec; 134(24):3259-3282. PubMed ID: 33346357
[TBL] [Abstract][Full Text] [Related]
20. Receptor-mediated Ca2+ and PKC signaling triggers the loss of cortical PKA compartmentalization through the redistribution of gravin.
Schott MB; Grove B
Cell Signal; 2013 Nov; 25(11):2125-35. PubMed ID: 23838009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
